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Medicinal plants are the major folk and traditional medicine for the prevention of diseases worldwide. Trianthema 
portulacastrum L. (family: Aizoaceae), a small perennial weed, found in the America, Africa, India, and other regions of the 
world, and are extensively used not only as medicine but also as vegetable for its various health benefits. Phytochemical 
analysis of T. portulacastrum reveals the presence of alkaloids, phytosterols, terpenoids, saponins, flavonoids and phenolic 
compounds. In vitro and in vivo studies have demonstrated its pharmacological and biological activities. Different parts of  
T. portulacastrum L. are conventionally being used as analgesic, anti-pyretic, lipid lowering and microbicide agent; and 
protect liver and kidney from carcinogen, inflammation and oxidant chemicals.  
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Introduction 
Medicinal plants are the major folk and traditional 
medicine for the prevention of diseases worldwide, 
especially in underdeveloped and developing  
countries, where the modern scientific treatment and 
therapies are challenging or expensive
1-3
. The global 
demand for herbal medicine is increasing. Compounds 
isolated from different herbs are used as key 
components to treat various diseases. A major share of 
FDA approved drugs has been reported directly  
or indirectly is based on natural products
1
. Many 
synthetic molecules resemble structural homology with 
various natural products that serve as leads
4
. India is 
the rich source of traditional medicinal systems, 
where out of 2500 species of medicinal plants,  
150 species are harvested for commercial use on a 
grand scale
5,6
.  
 
Trianthema porulacastrum L. 
Trianthema porulacastrum L. is a well-known 
medicinal plant used from ancient time to treat several 
diseases. T. portulacastrum L. (also called Trianthema 
monogyna L.)
7
, (family of Aizoaceae, also known as 
horse purslane, Bishkhapra, carpetweed, Punarnava, 
Gadabani and Labuni) has historically been valued  
by Indian and African cultures for its numerous 
medicinal properties
8,9
. The herb is found worldwide 
e.g. Southeast Asia (India, Bangladesh, Sri Lanka, 
Pakistan, etc.), Africa (like Ghana and Tanzania) and 
America. It grows in sunny desert as well as in 
irrigated and tropical rainfall areas. It‘s over growing 
nature is common in agricultural field especially in 
rainy seasons
10,11
. 
 
Botany 
T. portulacastrum is considered as annual or 
perennial depending on geographical area and the 
plant is propagated by seeds but the fragments of the 
stem can be spread by cuttings very easily. The plant 
is often succulent, branched, annual terrestrial and 
prostrate herb that produces colored flower (red or 
white color). Two varieties of the plant are found, one 
is red-flowered variety known as ‗Rakta Punarnava‘ 
—————— 
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Abbreviations: ACE, Angiotensin Converting Enzyme; AFB1, 
Aflatoxin B1; CA, caffeic acid; CAPE, Caffeic acid phenethyl 
ester; CCl4, Carbon tetrachloride; DENA, Diethylnitrosamine; 
DMBA, 7,12-dimethylbenz[a]anthracene; DPPH, 1,1-diphenyl-2-
picryl hydrazyl; FA, Ferulic acid; FLT3, Fms-like Tyrosine 
Kinase 3; GLUT, Glucose Transporter; HCC, Hepatocellular 
Carcinoma; HO-1, heme oxygenase-1; MDR, Multidrug 
resistance; NAFLD, Non-alcoholic fatty liver disease; NAPQI, N-
acetyl-p-benzoquinone; NF-κB, Nuclear factor-kappa B; Nrf2, 
Nuclear factor (erythroid-derived 2)-like 2; PDGFR, Platelet-
Derived Growth Factor Receptor; PHBA, p-hydroxy benzoic acid; 
ROS, Reactive oxygen species; RTK, Receptor Tyrosine Kinase 
family; STZ, Streptozotocin; TA, Thioacetamide; TASO, 
Thioacetamide S-oxide; TASO2, Thioacetamide S,S-dioxide; 
TNF-α, tumor necrosis factor-α; VA, Vanillic acid 
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or ‗Lal Sabuni‘ and white-flowered one is known as 
‗Shwet Punarnava‘ or ‗Svet Sabuni‘; and the former is 
more abundant
8
. The flowers are small, solitary, 
bisexual, pale pink or white in color and have stamens 
and white filaments. Both types are grown best under 
partial shade and flourish in neutral to alkaline soil. 
Few vernacular names are listed in (Table 1)
12-14
.  
The roots are thin, tortuous, slender, lateral 
branching fibrous. The leaves are succulent, green, 
opposite, oval shaped and unequal in size. The  
stems are branched, cylindrical, fleshy and angular to 
some extent and prostrate in nature. Fruit is 
circumsessile capsule like shaped that partly exerted 
from partial perianth containing 2-8 seeds. The seeds 
are hairless, kidney-shaped 1.5-2.5 mm long and 
black in color
7,12,15
. Pictorial form of the plant is 
shown in (Fig. 1).  
 
Nutritional value 
Trianthema portulacastrum L. is commonly used  
as vegetable in East Asian countries including India 
and in African countries especially, in Ghana, 
Cameroon and Tanzania
9
. This edible wild plant is  
a good source of carbohydrates, protein and minerals
16-18
. 
Trianthema portulacastrum L. contain approximately 
9% crude protein
18
, 3% carbohydrate
16
, and supply 
nearly 76 kcal energy/ 100 g
16
. This plant is easily 
digestable due to its simple structural carbohydrate in 
cell wall
19
. Storage form of energy (lipid) is about 
2%
16
. The leaves of T. portulacastrum contain nearly 
43% of crude fiber
20
. 
Vitamin A (~0.8 mg/g), vitamin B2 (~2.02 mg/g)
16
, 
Vitamin B3, vitamin C
21
, sodium (~44 mg /g), 
potassium (~51.6 mg/ g), copper (~20 mg/kg), zinc 
(~200 mg/kg), nickel (~30 mg/kg), iron (~6.44 mg/g) 
and manganese (40 mg/kg) were found in  
T. portulacastrum
16
.  
Different parts of T. portulacastrum are used 
traditionally as valuable source for pharmacological 
components that is used to treat alcohol poisoning, 
liver ailments, bronchitis, heart diseases, asthma, 
ascites, anemia, beri-beri, dropsy, corneal ulcers, 
edema, inflammation, migraine, rheumatism, piles and 
night blindness
17,21,22
. Both adverse and beneficial 
effects of T. portulacastrum ingestion have also been 
reported particularly in consumption of old leaves. It is 
reported that the consumption of old leaves causes 
diarrhea and paralysis both in humans and also in 
domestic animals. Seeds are also reported to have 
harmful effects
9
. But old leaves of T. portulacastrum 
are used to treat gonorrhea in Nigeria
23
. On the 
contrary, the root is used for diseases of the liver, 
spleen, and malignancy, while its leaves have been 
used for the treatment for diuretics diseases like edema 
and ascites in India, Africa and Asia
7
. The root is 
applied for the treatment of eye disorders like itching, 
corneal ulcer, night blindness and dimness of sight
22
.   
 
Phytochemicals 
Trianthema portulacastrum L. contains a wide 
range of secondary metabolites like carbohydrates, fats, 
tannins, terpenoides, flavonoides, steroids, alkaloids, 
saponins, cinnnamic acid derivatives and benzoic acid 
derivatives
24-27
. The main constituent tetraprenoid 
(trianthenol; 15-hydroxymethyl-2, 6, 10, 18, 22, 26,  
30-heptamethyl-14-methylene-17-hentriacontene) was 
isolated from chloroform extract having anti-fungal 
property
24
. Four more compounds such as 3-acetyl 
aleuritolic acid, 5-hydroxy-2-methoxy benzaldehyde,  
p-propoxy benzoic acid and p-methoxy benzoic  
acid were also reported
24
. Other tetraterpene and  
β-carotene were also reported21.  
Hydrocarbons were isolated from fresh leaves 
surface wax using gas liquid chromatography
28
.  
Total phenolic content varied within 50-98 mg  
gallic acid equivalents/g of dry weight. The flavonoids 
include 5,2'-dihydroxy-7-methoxy- 6,8-dimethylflavone  
(C-methylflavone) and 5,7- dihydroxy-6,8-dimethyl 
chromone (leptorumol)
27
. Few plant sterols, such as 
stigmasterol, β-sitosterol and β-glucopyranosides were 
isolated from dried plant
27
.
 
Alkaloids like trianthemine 
and punarnavine also found in this plant
29
. 
Table 1 — Vernacular names:[Anonymous 2003; Shanmugam 
2007; Zihad et al. 2019] [12-14] 
Language Name of Trianthema portulacastrum L. 
English Horse Purslane 
Bengali Gadabani, Swet punarnova, Kulpasag 
Hindi Santhi, Sabuni, Vishakhapara, Lalsabuni, 
Svetsabuni 
Sanskrit Shvetapunarnava, Chiratika, Dhanapatra, 
Shvetamula, Upothaki 
Tamil Sharunnai, Shavalai 
Telegu Ambatimadhu, Atikamamidi, Galijeru 
Bombay Svetapunarnava 
Punjab Bishkapra, itsit 
Kan. Muchchugoni 
Mal. Sharunnau 
Madras Mukkarattai 
Marathi Pundharighetntuli 
Urdu Narma 
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Fig. 1 — Phytochemicals available from Trianthema portulacastrum L. 
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Ecdysterone a plant steroid has been isolated  
from the whole plant
30. The red pigment β-Cyanin and 
3,4-dimethoxy cinnamic acid have been reported  
from this plant
31
. Others phytochemicals isolated  
from different parts of T. portulacastrum include 
vanillic acid, ferulic acid, p-hydroxybenzoic acid, 
protocatechuic acid, caffeic acid, pyrogallic acid and 
o-coumaric acid
32
. 
 
Biological activities of different phytochemicals 
available from T. portulacastrum: 
a. p-Methoxybenzoic acid exhibited hepatoprotective 
activity against carbon tetrachloride (CCl4) and 
paracetamol induced hepatotoxicity in vivo,  
and thioacetamide and galactosamine-induced 
hepatotoxicity in isolated rat hepatocytes
33, 34
.  
b. p-hydroxy benzoic acid (PHBA) has antimicrobial, 
antialgal, antimutagenic, antiestrogenic, anti-
inflammatory, anti-platelet aggregate, nematicidal, 
antiviral, antioxidant and hypoglycemic activities. 
It finds use in cosmetic products, pharmaceuticals, 
drugs preservative and food and beverages 
industry
35-37
. Derivatives of PHBA inhibit oedema 
induced by acetic acid and is used in sickle cell 
disease
35
. 
c. 5-hydroxy-2-methoxybenzaldehyde acts as an 
essential compound for the formation of bis 
(benzo[b]furan-2-yl)methanones that inhibit FLT3 
(Fms-like tyrosine kinase 3) and PDGFR (platelet-
derived growth factor receptor) which have been 
implicated in numerous pathological conditions 
like cancer and are the members of receptor 
tyrosine kinase (RTK) family
38
.  
d. 3-acetyl aleuritolic acid: Acetyl aleuritolic  
acids showed effect against S. aureus and  
S. typhimurium
39
. It also showed tumor-inhibitory 
properties toward the P-388 lymphocytic leukemia 
test system
40
. 3-O-acetylaleuritolic acid inhibited 
the proliferation and migration of cancer cell lines 
as well as contributed to autophagy induction 
showing some anticancer properties
41
, and 
exhibited significant inhibitory activities on the 
vitality of adult male worms of O. gutturosa
42
.  
e. Anti-proliferative activity of 5,7-dihydroxy-6,8-
dimethyl flavanone was evaluated on human 
colon cancer (HCT 116) cell line
43
.  
f. Phytosterols (β-Sitosterol, Stigmasterol) are 
widely present in vegetable oils, nuts, cereal 
products, fruits, and berries. Phytosterol compounds 
reduce the inflammatory reaction in LPS-induced 
macrophage models; and also inhibit the expression 
and activity of pro-inflammatory mediators
44
.  
β-sitosterol, the most common dietary 
phytosterol, lowers the cholesterol levels, enhances 
the production of plasminogen activators, and 
exhibits anticancer and antiatherogenic effects
45
. It 
enhances glycemic control by increasing the 
activation of insulin receptor and glucose 
transporter 4 (GLUT4) proteins in adipose tissue. 
In Silico analysis showed that β-sitosterol 
possesses the greater binding affinity with  
β-arrestin-2, c-Src, and IRS-1 as well as Akt 
proteins and attenuate insulin resistance. It also 
attenuates high fat diet-induced detrimental 
changes in adipose tissue
46
. It has been associated 
with cardiovascular protection by increasing the 
antioxidant defense system and effectively lowering 
the serum cholesterol level. It inhibits vascular 
adhesion molecule 1 and intracellular adhesion 
molecule 1 expression in TNF--stimulated human 
aortic endothelial cells
47
. 
β-sitosterol shows anti-inflammatory activity48.  
It can modulate the functions of macrophages  
and might be a promising agent for rheumatoid 
arthritis therapy
49
. It mediates the p53/NF-κB/ 
breast cancer resistance protein signaling axis and 
regulates the response of colorectal cancer to 
chemotherapy
50. β-Sitosterol can prospectively be 
used to mitigate diet-induced non-alcoholic fatty 
liver disease (NAFLD)
51
. It is useful for prevention 
of Alzheimer's disease, ameliorates memory and 
learning impairment in APP/PS1 mice and possibly 
decreases Aβ deposition52. It also contributes to  
the development of the compounds as anti-aging 
ingredients
53
.  
Stigmasterol showed antioxidant
54
, anti-inflammatory, 
hypoglycemic effect
48
 and antimicrobial activity
55
. 
It promoted transintestinal cholesterol secretion
56
. 
It has neuro-protective effect against the 
ischemic/reperfusion (I/R) injury, possibly 
associated with reduction of oxidative stress and 
inactivation of autophagy via AMPK/mTOR and 
JNK pathways
57
. It also inhibited growth of gastric 
cancer cells
58
. It acts as a precursor in the synthesis 
of progesterone and acts as an intermediate in the 
biosynthesis of androgens, estrogens, corticoids 
and in the synthesis of vitamin D3
59,60
. 
g. β-D-glucopyranoside derivative has been reported 
against influenza virus (H1N1)
61
. 
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h. Nitrogen-containing β-cyanins (red-violet) has 
been used as colorant in cosmetics and 
pharmaceuticals
62
. It is a scavenger of reactive 
oxygen species and exhibits gene-regulatory 
activity partly via nuclear factor (erythroid-derived 
2)-like 2-(Nrf2) dependent signaling pathways. 
This may induce phase II enzymes and antioxidant 
defense mechanisms
62
.  
i. β-carotene, important precursors of retinol 
(vitamin A), quench highly reactive singlet oxygen 
under certain conditions and can block free radical-
mediated reactions
63,64
. 
j. Quercetin and its main derivatives, such as 
rhamnetin, rutin, hyperoside, etc., are the major 
polyphenolic flavonoid found in food products, 
including berries, apples, cauliflower, tea, cabbage, 
nuts, and onions that have traditionally been 
treated as anticancer and antiviral, and used for the 
treatment of allergic, metabolic, and inflammatory 
disorders, eye and cardiovascular diseases,  
and arthritis. It has been examined against several 
pathogenic bacteria, viruses and parasites. It  
has shown beneficial effects against Alzheimer's 
disease, due to its inhibitory effect against 
acetylcholinesterase
65
. It is known for its free  
radical scavenging activity, anti-inflammatory,  
anti-hypertensive, vasodilator, anti-obesity, anti-
hypercholesterolemic and anti-atherosclerotic 
activities
66,67
. These critical properties of quercetin 
are responsible for anti-diabetic effect
68
 and 
controlling the pathogenesis of NAFLD
69
. In 
addition, its effect on proliferation, angiogenesis, or 
apoptosis, are considered as anti-tumor property to 
enhance breast cancer treatment
70
. Quercetin also 
demonstrated a significant protective effect on 
metronidazole-induced neuronal toxicity
71
.  
k. 3,4-dimethoxy cinnamic acid has been reported to 
have anti-oxidant activity
34
. 
l. Plant derived Ferulic acid (FA) is an antioxidant 
phenolic compound. Ferulic acid phenoxyl radical 
is considered as stable and unreactive, which 
contribute it‘s overall antioxidant activity72. It 
prevented methotrexate-induced hepatotoxicity by 
activating Nrf2/HO-1 (heme oxygenase-1) 
signaling and PPARγ, and attenuating oxidative 
stress, inflammation and cell death
73
. FA and 
derivatives acted as platelet aggregation inhibitor, 
tyrosinase-inhibitor, angiotensin converting enzyme 
(ACE) inhibitor, and superoxide dismutase like 
activities, and are involved in repair of blood 
vessel injury like thrombosis
74
.  
Ferulic acid causes cell cytotoxicity and 
apoptosis of HeLa and Caski cells, and the 
PI3K/Akt signaling pathway is down-regulated in 
Caski cells
75
. It preserves self-renewal in embryo 
stem cells, and contributes to adipose-derived 
mesenchymal stem cells self-renewal and effective 
weight control in obesity
76
. FA suppressed 
benzo(a)pyrene -induced toxicity in microglia, and 
exert neuroprotective effects by inhibiting 
microglia-mediated pro-inflammatory response
77
. 
Symptoms of osteoporosis include a reduction 
in bone strength, osteopenia, and damage to the 
bone microstructure. FA suppresses the fusion and 
apoptosis of mature osteoclasts, increase the 
mRNA and protein levels of SIRT1, reduced 
expression of nuclear factor-kappa B (NF-κB), and 
increase bone mineral density
78
. 
m. Caffeic acid (3,4-dihydroxycinnamic acid) showed 
antioxidant, anti-ischemia reperfusion, anti-
thrombosis, antihypertension, anti-fibrosis, antivirus 
and antitumor properties
79
. Caffeic acid (CA)-treated 
mice exhibited significantly lower levels of  
4-hydroxynonenal, an oxidative stress marker in the 
hippocampus, but no effect on the expression 
levels of neurotrophic factors and inflammatory or 
anti-inflammatory cytokines, as well as significantly 
fewer activated microglia
80
. It can be used to  
treat folliculitis, usually caused by a bacterial or 
fungal infection, due to its antioxidant potential  
and antimicrobial properties
81
. CA can prevent and 
delay the advanced glycation end products-induced 
vascular dysfunction in diabetes
82
. It can down 
regulate the miR-636 expression level, which is 
involved in development of diabetic nephropathy
83
. 
CA stimulates the expression of detoxification 
enzymes such as regulates HO-1, and glutamate-
cysteine ligase through the ERK/Nrf2 pathway, 
and it may be an effective chemoprotective agent 
for protecting liver damage against oxidative 
damage
84
. Caffeic acid has induced toxic effects 
and morphological changes in breast cancer cells  
via apoptosis
85
.  
Multidrug resistance (MDR) is a complicated 
ever-changing problem in cancer treatment, and  
P-glycoprotein (P-gp), a drug efflux pump, is 
regarded as the major cause. Caffeic acid is a 
promising candidate for P-gp inhibition and cancer 
MDR attenuation
86
. It can alleviate the cell damage 
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induced by overexpressing A53T α-synuclein and 
that CA reduced A53T α-synuclein by activating 
the JNK/Bcl-2-mediated autophagy pathway
87
.  
Caffeic acid phenethyl ester (CAPE) has various 
biological activities including antioxidant and anti-
inflammatory effect. CAPE decreases the bone 
resorption, enhances the bone healing, prevent 
alveolar bone loss and stimulate periodontal tissue 
healing
88
. CAPE significantly induces mRNA 
expression and production of VEGF in rat clonal 
odontoblast-like KN-3 cells cultured in normal 
medium or osteogenic induction medium. CAPE 
treatment enhances NF-κB transcription factor 
activation; up regulates the expression of VEGF 
receptor-2 and increase mineralization activity in 
KN-3 cells, and might be useful for the dental pulp 
conservative therapy
89
. 
Androgen receptor (AR) plays important role in 
the development, progression, and metastasis of 
prostate cancer and CAPE treatment reduces AR 
stability and AR transcriptional activity in PCa 
cells
90
. Caffeic acid esters are potent bactericidal 
compounds against Paenibacillus larvae and 
eliminate bacterial growth through an oxidative 
stress mechanism
91
. It is also a promising agent for 
the prevention of skin photoaging
92
. 
n. Cinnamic acid and derivatives have multipurpose 
functions, such as drugs for anti-tuberclosis, 
antidiabetic, antioxidant, antimicrobial, hepato- 
protective, CNS depressant, anti-cholesterolemic, 
antifungal, fungitoxic, anti-hyperglycemic, 
antimalerial, antiviral, anxiolytic, cytotoxic, anti-
inflammatory and UV rays absorbent
93
. Trans-
cinnamic acid showed effect against colon cancer 
in xenograft nude mice. Trans-cinnamic acid 
inhibit histone deacetylases in cancer cells
94
.  
o. Vanillic acid (VA), an oxidized form of vanilla, is 
a flavoring agent. VA improves oxidative stress in 
endothelial cells stimulated by palmitic acid by 
activating AMPK and its downstream proteins, and 
protect from diabetic vascular complications
95
. VA 
exerts cardioprotective effects against Doxorubicin-
induced cardiotoxicity by decreasing oxidative stress, 
suppressing TLR4 signaling and consequently 
inflammation pathway
96
. Anti-inflammatory and 
antioxidative properties of vanillic acid are associated 
with neuroprotective effects, resulting from Akt or 
ERK signaling activation. The activation of the 
mammalian target of rapamycin (mTOR), a key 
downstream target of Akt and ERK signaling, is a 
crucial therapeutic target for treating depression
97
. 
It alleviates osteoarthritis progression in a rat 
model by suppressing the IL-1β induced activation 
of MAPK and PI3K/AKT/NF-κB pathways98.  
Vanillic acid has a potent antibacterial and 
antibiofilm activity against carbapenem-resistant 
Enterobacter hormaechei and potential to be used in 
the food industry as a food preservative and surface 
disinfectant
99
. VA and derivatives have antihelmintic 
and antisickling activities, and suppress hepatic 
fibrosis in chronic liver injury
100,101
. 
p. Protocatechuic acid (PCA), a complex 
polyphenols of anthocyanins and procyanidins, 
possesses antioxidant, anti-inflammatory as well as 
antihyperglycemic and neuroprotective activities
102
, 
antibacterial, anticancer, anti-ageing, anti-atherogenic, 
anti-tumoral, anti-asthma, antiulcer, antispasmodic 
and neurological properties
103
. PCA also have 
chemopreventive activity as it can inhibit anti-
proliferative and pro-apoptotic effects induced by 
chemical carcinogenes
102
. 
Protocatechuic acid and its alkyl esters ethyl 
protocatechuate are promising candidates for the 
prevention and treatment of UVB-induced skin 
photodamage and photoaging caused by generation 
of reactive oxygen species (ROS)
104
. PCA-stimulated 
miR-219a-5p expression mitigates alcoholic liver disease 
by reducing p66shc-mediated ROS formation
105
. 
SIRT1 exhibits inhibitory effects on microglial 
activation-induced neurodegeneration. PCA inhibited 
the release of inflammatory mediators in LPS-
activated BV2 microglia via the SIRT1/NF-κB 
pathway and thereby attenuated microglial activation-
induced PC12 cell apoptosis
106
. It has potential to 
prevent Alzheimer's disease
107
. 
Protocatechuic acid attenuated anterior cruciate 
ligament transection-induced osteoarthritis by 
suppressing osteoclastogenesis by inhibiting the 
MAPK, ATK and NF-κB signaling pathways108. It 
shows protection against anticancer drug 
methotrexate-induced hepatorenal toxicity via 
antioxidant, anti-inflammatory, and antiapoptotic 
mechanisms
109
. Another study suggested that 
phytochemicals having antioxidant efficacy is 
responsible for detoxification
110
. 
q. Pyrogallic acid has anti-bacterial (cyanobacteria) 
activity
111,112
 and can also regulate the bacterial 
gene expression
112
. It is used in various industrial 
and consumer products. PA is autoxidized to 
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purpurogallin (PG), which is further autoxidized  
to other polyphenolic compounds. PA and PG  
might participate a futile redox cycle, which 
mediated ROS-induced toxicity in M. aeruginosa 
through oxidative damage to DNA strands and cell 
membrane
113
. 
r. O-coumaric acid has limited biological activity. It 
exerts anticarcinogenic and chemopreventive 
activity in human breast cancer cell (MCF-7) line. It 
showed regulatory role on p53 protein, Caspase-3 
protein and Bax and Bcl-2 protein and mRNA 
levels
114
. 
 
Toxicity study 
No toxicity was observed at dose of 3g/kg in mice 
model
25, 31
. No mortality was observed at dose of  
4 g/kg with methanolic extract of whole plant in rat 
model
115
. No atypical behavior was observed after 
intraperitonial administration of ethanolic extract at a 
dose of 250 mg/ kg in Swiss albino mice
13
. 
 
Pharmacological Activities  
 
Hypolipidemic activity 
Dyslipidemia is associated with cardiovascular 
diseases, obesity and other metabolic disorders
116
.  
T. portulacastrum exhibited the hypolipidemic 
activity by controlling triglyceride, total cholesterol, 
LDL-cholesterol and HDL-cholesterol in blood
117
 
(Table 2).  
 
Antimicrobial properties 
Plant extracts are reported to exhibit antibacterial 
activities
118
. T. portulacastrum showed anti-bacterial 
and anti-fungal activity
119
. Ethanolic extract of  
T. portulacastrum whole plant acted against gram 
positive bacteria
120
. Aqueous, methanolic and 
chloroform extracts showed antibacterial properties 
against Escherichia coli, Salmonella typhi, 
Pseudomonas aeruginosa, Staphylococcus aureus, 
Klebsiella pneumoniae, and Shigella flexneri
26
. Root 
extract of T. portulacastrum exhibited antibacterial 
activity against Proteus vulgaris, Bacillus subtilis, 
Staphylococcus aureus, Escherichia coli, and 
Pseudomonas aeruginosa
121
.  
Trianthenol-1 isolated from chloroform extract of 
T. portulacastrum acted moderately against fungal 
pathogens
24
. The flavonoid fraction of chloroform and 
methanolic extracts of T. portulacastrum showed anti- 
fungal activity against human pathogens such as 
Candida albicans, Aspergillus fumigates, A. niger,  
A. flavus and Rhizopus oryzae, but showed no effect 
against Mucor spp
26
.  
 
Anthelmintic, larvicidal, hormonal and chemosterilant 
activity 
Antihelmintic activity against Haemonchus 
contortus (female) and their eggs were observed by 
aqueous methanolic crude extract of T. portulacastrum 
in vitro and in sheep model after infecting with 
nematodes (roundworms) species in vivo
122
. Aqueous 
and acetone extract also showed larvacidal activity 
against Culex quinquefasciatus, Anopheles stephensi 
and Aedes aegypti
123
. 
Hormonal regulation of T. portulacastrum was 
reported in in vivo insect model
124,125
. Ecdysterone 
(phytoecdysone) from T. portulacastrum (whole plant) 
demonstrated chemosterilant activity through molting 
hormonal activity in larvae of house fly (Musca 
domestica)
124
. 
 
Antifertility activity 
Chloroform, aqueous and alcoholic extract of  
T. portulacastrum leaves, stem and roots acts as a 
potential pregnancy interceptive, at dose of 100, 200 
and 400 mg/kg body weight
23
.  
 
Analgesic, antipyretic and antinociceptive activity 
Ethanolic extract of T. portulacastrum whole plant 
elicited considerable reduction on writhing response 
in acetic acid induced mice. 250 mg/kg of such 
extract demonstrated similar effect like aspirin
13
. 
Podo dolorimeter measurement (measure voltage 
threshold) showed significant result in mice; however 
thermal caudal immersion and mechanical tail clip 
techniques failed to reveal any fruitful result
120
.  
The extract also had antinocicepative activity 
equivalent to drug aspirin in mice determined by  
hot-plate reaction time model
13
. Antipyretic activity 
of T. portulacastrum was observed by whole plant 
ethanolic extract (50 mg/kg, i.p.) in rat induced by 
yeast pyrexia
120
. 
 
Nephroprotective, Diuretic and Antilithiatic activity 
Ethanolic leaf extract of T. portulacastrum showed 
protection against nephrotic syndrome induced by 
adriamycin
126
 (generic name doxorubicine, a drug used 
to treat cancer patients) and gentamicin
127
 (drug known 
as aminoglycoside, used to treat wide range of bacterial 
infection) in rat by decreasing blood urine nitrogen, 
serum chloresterol and creatinin level, and by 
increasing serum protein and albumin level. Methanolic 
extract of T. Portulacastrum showed nephroprotective 
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Table 2 — Pharmaceutical Activity 
Plant extract 
type 
Animal model & 
Microorganism 
Dose  
(body weight) 
Study time Route Toxic control Result Reference 
Ethanolic  Female Sprage  
Dawley Rat 
50,100, and 
200 mg/kg 
16 week p.o. 7,12-dimethylbenz (a) 
anthracene 
Chemopreventive 
activity against brest 
cancer 
204 
Ethanolic  Male wistar rat 100 mg/kg 7 day p.o. Aflatoxin Hepatoprotective 181 
Ethanolic  Male wistar rat 100, 200 
mg/kg 
21 day p.o. Aflatoxin Antihepatotoxic 180 
Ethanolic  Male and female  
wistar rat 
100, 200 
mg/kg 
10 days p.o. Thioacetamide and 
paracetamol 
Hepatoprotective 161 
Ethanolic Male Swiss albino 
mice 
150 mg/kg 13 week p.o. CCl4 Hepatoprotective 171 
Ethanolic Male Swiss albino 
mice 
50, 100, 150 
mg/kg 
3 days p.o. CCl4 Hepatoprotective 169 
Ethanolic Male Swiss albino 
mice 
100, 150 
mg/kg 
7 week p.o. CCl4 Antihepatotoxic 
effect 
150, 151 
Ethanolic  Male and female  
wistar rat 
100, 200 
mg/kg 
2 week p.o. Thioacetamide (150 
mg/kg) and 
paracetamol (3 g/kg) 
Antioxidant 162 
Ethanolic  Male wistar rat 100, 200 
mg/kg 
10 days p.o. Atherosclerotic diet Renoprotective and 
Hepatoprotective 
128 
Ethanolic Mice - 7 days - Aspirin and Acetic Analgesic activity 
and antin ociceptive 
activity 
13 
Metanolic  In vitro 10 µL  -  Free radical 
Scavenging 
134 
Methanolic In vitro 1,10,100,1000,
2000,5000 
µg/mL 
   Radical scavenging 
and anti-oxidant 
activity 
135 
Methanolic  Wistar albino rats 100, 200, 300 
mg/kg 
7 days i.p. Alloxen Hypoglycemic and 
hypolipidemic 
117 
Methanolic Male wistar albino rat 100, 200 
mg/kg 
7 days p.o. Streptozocin Antihyperglycemic 31 
Aqueous 
methanolic  
Male & female sheep 1,4 & 8 g 15 days p.o. - Anthelmintic 122 
Aqueous Albino rat 10, 30& 50 
mg/kg 
- i.p. - Antidiuretic 25 
Aqueous, 
alcoholic 
&chloroform 
Female wistar rat 100,200 & 
400 mg/kg 
5 day p.o. - Antifertility activity 23 
Aqueous, 
ethanolic and 
chloroform 
Male Sprage Dawley 
Rat 
100, 200 
mg/kg 
22 week p.o. Diethynitroso-amine Anticarcinogenic 127, 207, 208 
Aqueous and 
ethanolic 
In vitro (paper disc 
diffusion) 
20 µL    Antibacterial 
activities 
209 
Chloroform  In vitro (Candida 
Albicans, A. 
fumigatus 
20 µL 2 days -  Antifungal 24 
Aqueous & 
acetone 
Culex 
Quinquefasciatus, 
Anopheles stephensi 
and Aedes aegypti 
1, 0.75, 0.75 
and 1% 
4 week - - Larvacidal 123 
Whole plant In vitro - - - - Fodder potential & 
nutritive value 
19 
(Contd.) 
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Table 2 — Pharmaceutical Activity 
Plant extract 
type 
Animal model & 
Microorganism 
Dose  
(body weight) 
Study time Route Toxic control Result Reference 
Aqueous, 
methanolic 
and 
chloroform 
In vitro  
(bacterial and fungal) 
20 µL 48 h -  Antifungal & 
antibacterial activity 
26 
n-butanol, 
hexane, 
chloroform 
and ethyl 
acetate 
In vitro  
(bacterial and fungal) 
20 µL    Antifungal & 
antibacterial activity 
119 
 
effect in renal injury, damged by artherosclerotic diet 
in rat
128
.  
Aqueous extract of T. portulacastrum showed 
significant diuretic activity against non-treated and 
furosemide treated rats at dose of 10 mg/kg
26
. Hydro 
alcoholic leaf extract of T. portulacastrum also 
reported natriuretic effects in rat model
129
. 
Ethylene glycol is metabolised to glycolate by 
alcohol dehydrogenase, causing acidosis that 
precipitates crystal of calcium oxalate monohydratein. 
Renal, kidney injury, nervous system depression and 
cardiopulmonary failure is the cause of ethylene 
glycol poisoning
130,131
. The ethanolic extract of  
T. portulacastrum showed antilithiatic effect in 
ethylene glycol induced urolithiasis in male wistar 
rats at dose of 200 and 400 mg/kg b.w and found that 
urine output, phosphate, calcium, oxalate and 
magnesium level in urine, urea, creatinine and uric 
acid in blood level reestablished at near normal value 
after treatment
132
. 
 
Anti-inflammatory activities 
Ethanolic extract of T. portulacastrum whole plant 
at dose of 100 mg/kg (i.p.) showed significant anti-
inflammatory response against formaldehyde induced 
arthritis
120,133
.  
 
Antioxidant activities 
T. portulacastrum extract showed free radical 
scavenging activity against hydrogen peroxide and 
DPPH (1,1-diphenyl-2-picryl hydrazyl)
134
, ferric-
reducing power and reversed the action of linoleic 
acid peroxidation activity
135
. Root extract showed 
greater inhibition effect against linoleic acid 
peroxidation compare to other parts
135
. Ethanolic 
extract of T. portulacastrum showed protection 
against radiation-induced oxidative damage in red 
blood cells membrane. It optimizes the radiation-
induced elevated level of TBARS and inhibits 
ATPase activity in RBC membrane ghosts
136
. The 
presence of phenols, flavonoids and tannins, in 
particular, attenuates ROS
137
. 
 
Antihyperglycemic 
Alloxan and streptozotocin are used to induce 
diabetes in animal through destruction of pancreatic B 
cell and DNA damage, respectively. Alloxan (2,4,5,6-
tetraoxypyrimidine; 5,6-dioxyuracil)-induced diabetes 
has been commonly utilized as an animal model of 
insuln-independent diabetes mellitus. Alloxan and 
reduction product dialuric acid establish a redox 
cycle. Superoxide radicals, hydrogen peroxide and 
hydroxyl radicals are produced like a chain reaction. 
The action of ROS with a simultaneous massive 
increase in cytosolic calcium concentration causes 
rapid destruction of B cells
138
. 
Streptozotocin (STZ), an antibiotic with broad-
spectrum activity, was isolated from a soil micro-
organism Streptomyces achromogenes
139
. STZ has 
been widely used to generate an animal model of 
T1DM, because STZ-induced diabetes structurally, 
functionally, and biochemically resembles human 
T1DM
140,141
. Low affinity glucose transporter 2 
(GLUT2) mediates the entry of STZ into the cells. It 
is known that GLUT2 is highly expressed in the liver, 
intestine, basolateral surface of kidney, pancreatic  
β-cells, and central nervous systems142, 143. Cells that 
express GLUT2 are sensitive to STZ
144
. STZ has 
diverse cytotoxic effects such as aberrant DNA 
alkylation, protein methylation and generation of 
reactive oxygen and nitrogen species (RONS)
145
. 
Excess RONS trigger cell death during early stages
146
, 
impairs mitochondrial respiratory complex, inhibits 
aconitase activity, and transforms mitochondrial 
membrane potential, resulting in the disturbance in 
mitochondrial bioenergetics
147
. The pancreas is more 
vulnerable to oxidative stress than any other tissues 
because of the low level of antioxidant 
enzymes
145,148,149
. These effects of STZ are responsible 
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for necrosis of pancreatic β-cells138. Methanolic extract of 
T. portulacastrum whole plant yield anti-hyperglycemic 
activity against STZ (streptozotocin) induced diabetic 
rat
31
, as well as alloxan stimulated hyperglycemic rat
117
. 
These results are comparable to oral hypoglycemic drug. 
 
Hepatoprotective effects 
The hepatoprotective activity of T. portulacastrum 
is maintained by regulation of immunity and 
erythropoiesis
150
, antioxidant enzymatic activity
151
.  
Overdose (>4 g/day) of antipyretic drug paracetamol/ 
acetaminophen causes hepatotoxicity. Paracetamol 
excreted as glucoronide and sulphate conjugates  
through urine. Electrophilic intermediate N-acetyl-p-
benzoquinone imine (NAPQI) formed by isoenzyme of 
cytochrome CYP2E1 is responsible for hepatotoxicity 
caused due to excess intake of paracetamol. Trace 
amount of NAPQI can be inactivated by glutathione, but 
excess amount of NAPQI deplete glutathione. Higher 
amount of NAPQI bind with hepatic protein 
covalently that causes cell death
152
. In nutshell, 
mechanism of liver injury (necrosis) is dependent on  
the accumulation of acetaminophen metabolites, 
NAPQI, NAPQI protein adducts, glutathione depletion, 
oxidative stress, and mitochondrial damage
153,154
.  
The inflammatory cytokines, such as TNF-α, IFN-γ, and 
IL-1β are also crucial for the development of 
acetaminophen hepatitis
155
. The NK and NKT cells play 
a detrimental role
156,157
. The underlying liver injury was 
mediated by production of IFN-γ, chemokines, and  
up-regulation of FasL expression in the liver
158
. 
Thioacetamide (TA) causes necrosis that lead  
to hepatotoxicity. Highly reactive thioacetamide  
S,S-dioxide (TASO2) produced from intermediate 
thioacetamide S-oxide (TASO) formed by oxidative 
bioactivation of thioacetamide. TASO2 alter protein 
structure and amine lipids causing hepatic damage
159
. 
TA also decreases the GSH level in hepatocyte that 
increases the ROS production including lipoperoxidation 
level, leading to mitochondrial injury and cell death
160
. 
Ethanolic leaf extract of T. portulacastrum demonstrated 
hepatoprotective activity against toxicity induced by 
thioacetamide and paracetamol
161
 due to its antioxidant 
potential
162
. 
Carbon tetrachloride (CCl4) is a potent hepatotoxin, 
induces acute and chronic hepatitis
163
. CCl4 activates 
cytochromes (CYP2E1, CYP2B1 or CYP2B2) to 
form trichloromethyl (CCl3) radical that reacts with 
oxygen to form a highly reactive oxygen species 
(ROS) CCl3OO* that initiate lipid peroxidation, 
denaturation of polyunsaturated fatty acids, mitochondria 
dependent liver injury and fatty degeneration
164
. As a 
result, the mitochondrial, endoplasmic reticulum and 
plasma membrane permeability is lost with deregulation 
of Ca
2+
 in the cells leading to cellular demise
164
. 
Additionally, CCl4 toxicity leads to hypomethylation of 
cellular components and liver damage
164
. The increased 
influx of cytokines, chemokines and immune cells like 
neutrophils, following CCl4-induced liver injury result in 
hepatocyte damage (necrosis)
165
. The Kupffer cells 
(KCs) also play a vital role in CCl4-mediated hepatitis 
in mice as depletion of KCs protects CCl4-induced 
liver necrosis and IL-6 production
166
. Another study 
demonstrated that CCl4-mediated hepatitis was 
dependent upon the activity of KCs via TNF-α and 
FasL
167
. It causes fat degeneration and lipid 
accumulation in the liver causing loss of enzyme 
functions like glucose-6-phosphatases and cytochrome 
P-450 monooxygenase. CCl4 is also responsible for 
reversible blocking of intracellular gap junction 
immediately after intoxication, leading to impaired 
movement of calcium and consequently cell death
168
. 
Ethanolic extract of T. portulacastrum showed 
protective effect against CCl4 induced hepatotoxicity 
in mice
169
. This protective activity is comparable with 
the standard hepato-protective silymarin drug
170
. It 
showed protective effect on early DNA damage and 
chromosomal anomaly in mouse liver damaged by 
CCl4
171
. Free radical scavenging activity and antioxidant 
property of ethanolic extract of T. portulacastrum 
reduces lipid peroxidation in CCl4 induced mice 
model
151
, as observed its hepatic destruction by 
histopathological, hematological and biochemical 
parameters in liver after oral administration of the  
T. portulacastrum extract on Swiss albino mice
150
.  
Aflatoxins (mycotoxins) are mostly produced by 
Aspergillus flavus, Aspergillus parasiticus and 
Aspergillus nomius
172
. Few other species of Aspergillus 
and Emericella are also reported to produce 
aflatoxins
173
. It has been reported that more than 18 
different types of aflatoxins occur in nature, among them 
B1, B2, G1 and G2 mostly affect animals and humans. 
These aflatoxins cause toxic effects leading to 
mutagenicity, carcinogenicity and hepatotoxicity
174
. 
Aflatoxin B1 (AFB1) has been considered to be more 
toxic than other aflatoxins
174
. The liver is a primary 
target for AFB1, along with the heart, kidney, lungs, 
testis and bone marrow
174
.  
Orally treated AFB1 is absorbed in the small 
intestines and metabolised in the liver. In the liver, 
AFB1 is biotransformed by microsomal cytochrome 
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P450 to a highly reactive intermediate, AFB1-8,  
9-epoxide, which binds to nucleic acids to form 
adducts
175
. These adducts could block transcription 
and translation, thereby affecting the regulation of 
functional gene expression and ultimately causing 
hepatotoxicity
175
. AFB1-induced hepatotoxicity also 
results from accumulation of ROS, interact with DNA 
and lead to mutations
175
. Acute aflatoxicosis resulting 
from exposure to high doses of AFB1 through the diet 
over a short period causes hepatotoxicity while 
chronic aflatoxicosis resulting from exposure to low 
doses of AFB1 through the diet over a long period of 
time has been implicated in hepatocellular carcinoma
176
.  
Caspases are critical mediators of apoptotic cell 
death where caspase-3 is activated by mitochondria-
dependent (intrinsic) and independent (extrinsic) cell 
death pathways
177
. Bax, a pro-apoptotic protein 
induces the transport of cytochrome c from the outer 
membrane of mitochondrial to the cytosol, and the 
anti-apoptotic protein Bcl-2 is involved in releasing 
cytochrome c
178
. AFB1 was included in the 1st class 
human carcinogen group by the International Agency 
for Research on Cancer in 1993
179
. Pretreatment of 
mouse with ethanolic leaves extract of T. portulacastrum 
(administered orally) showed aflatoxin B1 (AFB1, a 
hepatocarcinogenic) stimulated hepatotoxicity
180
. 
Another study showed that administration of extract at 
dose 50-800 mg/kg four times in 3 h interval exerted 
hepatoprotection
181
.  
Methanolic extract of T. portulacastrum reduced lipid 
and cholesterol level in serum and protected against 
hepatocellular damage induced by atherosclerotic diet 
(0.5% thiouracil, 1% cholic acid and 4% cholesterol) 
observed in rat
128
.  
 
Antioxidant and Protective Mechanism 
A basal level of activity by these defensive 
systems of cells appears to be sufficient to protect 
cells against various oxidative stresses under normal 
conditions. Redox-responsive transcription factor, 
Nrf2 is the chief regulator of cellular homeostasis. 
Nrf2 mediates the expression of numerous oxidative 
stress related genes, including antioxidant proteins, 
phase I and II detoxification enzymes, transport 
proteins, proteasome subunits, chaperones, growth 
factors and their receptors, and some transcription 
factors
182-184
.  
Under basal conditions, Nrf2 is primarily regulated 
by the Kelch-like ECH-associated protein1 (Keap1), 
an adaptor protein of the Cullin3 (Cul3) based  
E3-ligase. This Cul3-E3 ubiquitin ligase complex 
mediates the proteasomal degradation of Nrf2. Under 
normal physiological conditions, Keap1 constitutively 
targets Nrf2 for ubiquitin-dependent proteasomal 
degradation. Keap1 is inactivated during oxidative 
stress, and the ubiquitination of Nrf2 stops, which 
leads to conformational changes in the Nrf2-Keap1-
Cul3 complex, and activate Nrf2.  Activated Nrf2 
translocate into the nucleus and binds to the 
antioxidant response element (ARE) located in the 
promoter region of Nrf2 target genes. Consequently, it 
induces the transcription of cytoprotective genes, 
leading to the activation of the defensive system
185, 186
. 
Nrf2 is primarily expressed in metabolically active 
organs such as the liver
187
. The phytochemicals 
present in fruits and vegetables have been shown to 
specifically react with the cysteine residues of Keap1 
leading to a conformational change, which results in 
diminished tagging of Nrf2 for proteolysis. Thus, 
phytochemicals from T. portulacastrum activated 
Nrf2, which might be beneficial in protecting against 
liver injury
188-190
. 
 
Anticarcinogenic activity 
Diethylnitrosamine (DENA) is a carcinogenic 
agent and plays an important role in cell cycle 
regulation. DENA induces hepatocellular carcinoma 
(HCC) through over expression of regulatory protein 
of G1/S phase in rat
191
. It has been proposed that 
DENA-induced HCC in mice models has closer 
histologic and genetic features to those observed in 
human HCC of poor prognosis than others HCC 
models
192
. DENA is biotransformed by cytochrome 
P450 enzymes into an ethyldiazonium ion, an 
electrophile that forms DENA-DNA adducts, with 
concomitant release of ROS
193-195
. Both oxidative 
stress and DNA adduct formation contribute to DENA 
carcinogenicity. T. portulacastrum extract showed 
chemo preventive activity in Sprague–Dawley rat 
model exposed by DENA
196
. Chloroform extract also 
exhibited protection against hepatocarcinogenesis 
initiated by DENA and Phenobarbital
197
.  
7,12-dimethylbenz[a]anthracene or DMBA, a 
polycyclic aromatic hydrocarbon, is one of the major 
carcinogenic components of car and industrial exhaust 
and char-broiled food
198
. It initiates and promotes 
tumorigenesis, especially in the breast, ovary and skin 
depending on the route of exposure
199
. It has been 
reported that DMBA activates the aryl hydrocarbon 
receptor (AhR) transcription factor that regulates a 
number of genes involved in cellular metabolism
200
. 
AhR upregulate the cytochrome P450 enzymes and 
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metabolizes DMBA into a mutagenic intermediate 
that causes DNA damage and is responsible for the 
initiation of tumorigenesis
201,202
. DMBA up regulate the 
expression of Cyclin D1 and c‑Myc, possibly through 
NF‑κB and Wnt pathways, and play critical role in 
carcinogenesis
203
. Ethanolic extract of T. portulacastrum 
showed chemopreventive activity against DMBA-
induced tumorigenic mammary gland in female 
Sprague-Dawley rats
204
. 
 
Oxidative stress and Microenvironment in Cancer 
Oxidative stress is involved in different stages of 
carcinogenesis; initiation, promotion and progression. 
Free radicals activate numerous mechanisms at the 
initiation step and contributing to mutations. In the 
promotion step initiated cells either enhances the 
proliferation and/or inhibits the cell death. During the 
progression step, free radicals cause uncontrolled growth 
of tumor cells, resistance to chemotherapy, genomic 
instability, metastasis and invasion
205
. Antioxidants from 
phytochemicals, such as T. portulacastrum, detoxify free 
radicals and ROS directly or indirectly, and thus may 
protect against cancer
206
. 
 
Conclusion 
Trianthema portulacastrum L. has shown its 
potential as nutritional plant as well for the remedial 
purposes in different medical purposes, such  
as inflammation, microbial infection, antioxidant, 
hyperglycemia, nephropathy and cancer etc. The 
phytochemicals present in T. portulacastrum are 
responsible for health benefits. Available evidences 
suggest that antioxidant property of this plant is one 
of the major factors responsible for its beneficial 
effects. On the contrary, understanding of the detailed 
protective mechanisms in several medical conditions 
is yet to be elucidated. Extensive study on the 
available phytochemicals from T. portulacastrum and 
elucidation of their mechanism on action will help to 
develop new drug(s) in several ailment conditions at a 
low cost due to its abundant availability. 
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